Boston Scientific's MADIT-CRT study shows sustained survival benefit for mild ... pharmabiz.com In the longest follow-up to date of Cardiac Resynchronisation Therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's exclusively sponsored and landmark Multicentre Automatic Defibrillator Implantation Trial Cardiac ... |
